C353H246N34O — CID 159079968
3,6-ditert-butyl-9-[8-(3,6-ditert-butylcarbazol-9-yl)-2,3-dipyridin-3-ylquinoxalin-5-yl]carbazole;10-[4-[5,8-di(carbazol-9-yl)quinoxalin-2-yl]phenyl]-9,9-dimethylacridine;10-[4-[5,8-di(carbazol-9-yl)quinoxalin-2-yl]phenyl]phenoxazine;5-[4-[5,8-di(carbazol-9-yl)quinoxalin-2-yl]phenyl]-10-phenylphenazine;10,13-di(carbazol-9-yl)-3-N,3-N,6-N,6-N-tetraphenylphenanthro[9,10-b]quinoxaline-3,6-diamine;3,6,10,13-tetra(carbazol-9-yl)phenanthro[9,10-b]quinoxaline (PubChem CID 159079968) has the molecular formula C353H246N34O and a molecular weight of 4980.09 g/mol. Its IUPAC name is 3,6-ditert-butyl-9-[8-(3,6-ditert-butylcarbazol-9-yl)-2,3-dipyridin-3-ylquinoxalin-5-yl]carbazole;10-[4-[5,8-di(carbazol-9-yl)quinoxalin-2-yl]phenyl]-9,9-dimethylacridine;10-[4-[5,8-di(carbazol-9-yl)quinoxalin-2-yl]phenyl]phenoxazine;5-[4-[5,8-di(carbazol-9-yl)quinoxalin-2-yl]phenyl]-10-phenylphenazine;10,13-di(carbazol-9-yl)-3-N,3-N,6-N,6-N-tetraphenylphenanthro[9,10-b]quinoxaline-3,6-diamine;3,6,10,13-tetra(carbazol-9-yl)phenanthro[9,10-b]quinoxaline.
| Compound Name | 3,6-ditert-butyl-9-[8-(3,6-ditert-butylcarbazol-9-yl)-2,3-dipyridin-3-ylquinoxalin-5-yl]carbazole;10-[4-[5,8-di(carbazol-9-yl)quinoxalin-2-yl]phenyl]-9,9-dimethylacridine;10-[4-[5,8-di(carbazol-9-yl)quinoxalin-2-yl]phenyl]phenoxazine;5-[4-[5,8-di(carbazol-9-yl)quinoxalin-2-yl]phenyl]-10-phenylphenazine;10,13-di(carbazol-9-yl)-3-N,3-N,6-N,6-N-tetraphenylphenanthro[9,10-b]quinoxaline-3,6-diamine;3,6,10,13-tetra(carbazol-9-yl)phenanthro[9,10-b]quinoxaline |
|---|---|
| PubChem CID | 159079968 |
| Molecular Formula | C353H246N34O |
| Molecular Weight | 4980.09 g/mol |
| Exact Mass | 4976.02 |
| IUPAC Name | 3,6-ditert-butyl-9-[8-(3,6-ditert-butylcarbazol-9-yl)-2,3-dipyridin-3-ylquinoxalin-5-yl]carbazole;10-[4-[5,8-di(carbazol-9-yl)quinoxalin-2-yl]phenyl]-9,9-dimethylacridine;10-[4-[5,8-di(carbazol-9-yl)quinoxalin-2-yl]phenyl]phenoxazine;5-[4-[5,8-di(carbazol-9-yl)quinoxalin-2-yl]phenyl]-10-phenylphenazine;10,13-di(carbazol-9-yl)-3-N,3-N,6-N,6-N-tetraphenylphenanthro[9,10-b]quinoxaline-3,6-diamine;3,6,10,13-tetra(carbazol-9-yl)phenanthro[9,10-b]quinoxaline |
| SMILES | CC(C)(C)c1ccc2c(c1)c1cc(C(C)(C)C)ccc1n2-c1ccc(-n2c3ccc(C(C)(C)C)cc3c3cc(C(C)(C)C)ccc32)c2nc(-c3cccnc3)c(-c3cccnc3)nc12.CC1(C)c2ccccc2N(c2ccc(-c3cnc4c(-n5c6ccccc6c6ccccc65)ccc(-n5c6ccccc6c6ccccc65)c4n3)cc2)c2ccccc21.c1ccc(N(c2ccccc2)c2ccc3c(c2)c2cc(N(c4ccccc4)c4ccccc4)ccc2c2nc4c(-n5c6ccccc6c6ccccc65)ccc(-n5c6ccccc6c6ccccc65)c4nc32)cc1.c1ccc(N2c3ccccc3N(c3ccc(-c4cnc5c(-n6c7ccccc7c7ccccc76)ccc(-n6c7ccccc7c7ccccc76)c5n4)cc3)c3ccccc32)cc1.c1ccc2c(c1)Oc1ccccc1N2c1ccc(-c2cnc3c(-n4c5ccccc5c5ccccc54)ccc(-n4c5ccccc5c5ccccc54)c3n2)cc1.c1ccc2c(c1)c1ccccc1n2-c1ccc2c(c1)c1cc(-n3c4ccccc4c4ccccc43)ccc1c1nc3c(-n4c5ccccc5c5ccccc54)ccc(-n4c5ccccc5c5ccccc54)c3nc21 |
| InChI | InChI=1S/C68H40N6.C68H44N6.C58H58N6.C56H36N6.C53H37N5.C50H31N5O/c1-9-25-55-43(17-1)44-18-2-10-26-56(44)71(55)41-33-35-51-53(39-41)54-40-42(72-57-27-11-3-19-45(57)46-20-4-12-28-58(46)72)34-36-52(54)66-65(51)69-67-63(73-59-29-13-5-21-47(59)48-22-6-14-30-60(48)73)37-38-64(68(67)70-66)74-61-31-15-7-23-49(61)50-24-8-16-32-62(50)74;1-5-21-45(22-6-1)71(46-23-7-2-8-24-46)49-37-39-55-57(43-49)58-44-50(72(47-25-9-3-10-26-47)48-27-11-4-12-28-48)38-40-56(58)66-65(55)69-67-63(73-59-33-17-13-29-51(59)52-30-14-18-34-60(52)73)41-42-64(68(67)70-66)74-61-35-19-15-31-53(61)54-32-16-20-36-62(54)74;1-55(2,3)37-17-21-45-41(29-37)42-30-38(56(4,5)6)18-22-46(42)63(45)49-25-26-50(54-53(49)61-51(35-15-13-27-59-33-35)52(62-54)36-16-14-28-60-34-36)64-47-23-19-39(57(7,8)9)31-43(47)44-32-40(58(10,11)12)20-24-48(44)64;1-2-16-38(17-3-1)59-49-26-12-14-28-51(49)60(52-29-15-13-27-50(52)59)39-32-30-37(31-33-39)44-36-57-55-53(61-45-22-8-4-18-40(45)41-19-5-9-23-46(41)61)34-35-54(56(55)58-44)62-47-24-10-6-20-42(47)43-21-7-11-25-48(43)62;1-53(2)40-19-7-13-25-47(40)56(48-26-14-8-20-41(48)53)35-29-27-34(28-30-35)42-33-54-51-49(57-43-21-9-3-15-36(43)37-16-4-10-22-44(37)57)31-32-50(52(51)55-42)58-45-23-11-5-17-38(45)39-18-6-12-24-46(39)58;1-5-17-39-34(13-1)35-14-2-6-18-40(35)54(39)45-29-30-46(55-41-19-7-3-15-36(41)37-16-4-8-20-42(37)55)50-49(45)51-31-38(52-50)32-25-27-33(28-26-32)53-43-21-9-11-23-47(43)56-48-24-12-10-22-44(48)53/h1-40H;1-44H;13-34H,1-12H3;1-36H;3-33H,1-2H3;1-31H |
| InChIKey | KASQCJJGPMVVEN-UHFFFAOYSA-N |
| XLogP | 92.25 |
| TPSA | 278.15 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 29 |
| Heavy Atoms | 388 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4980.09 |
| LogP ≤ 5 | 92.25 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 35 |